Page 5,267«..1020..5,2665,2675,2685,269..5,2805,290..»

Risks of cerebral palsy stem cell treatment

Posted: Published on May 23rd, 2013

An expert panel of scientists and clinicians is warning people against going overseas for costly and unproven stem cell treatment for cerebral palsy. A forum held in Sydney last night heard from leading researchers in the field and a parent who sought treatment in the United States for his young son. The Cerebral Palsy Alliance estimates as many as 500 Australians have sought stem cell therapies overseas. But the alliance last night urged families to hold out for the possibility that Australia will undertake its own clinical trials of the treatment as early as this year. "We're very worried about families travelling overseas for treatment," Associate Professor Iona Novak, from the alliance, said. "A lot of these stem cell tourism companies don't even describe what type of cells they're giving, so first we don't even know if they're human cells... so, of course, it is a very risky procedure. "There has been a couple of cases internationally of children actually dying from these treatments." The alliance estimates a child in Australia is born with cerebral palsy every 15 hours, making it the most common disability in childhood. The condition is caused by damage to the child's brain during pregnancy, birth … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Risks of cerebral palsy stem cell treatment

MS Patients Choose Death Risk With Potent Drug Treatment

Posted: Published on May 23rd, 2013

Kari Antin, a 40-year-old financial analyst in Minneapolis, knows shes taking a life-or-death risk with every monthly infusion of Biogen (BIIB) Idec Inc.s Tysabri. She is among the 55 percent of multiple sclerosis patients who harbor a potentially lethal virus that can be reactivated by the drug, allowing it to creep from the kidneys to the brain, where it destroys cells that protect the nerves. The risk soars after two years of treatment. Still, Antin insists on sticking with the drug she credits with restoring her health. Its a dilemma faced by almost 60,000 multiple sclerosis patients worldwide who continued on Tysabri beyond the recommended two years. Its also new territory for Biogen, as the number of patients pushing the time limit increases, and a concern for prescribing doctors who increasingly find patients resolute about staying on the potent medicine that reduces the risk of relapse by 68 percent. I dread the thought of being in a wheelchair, said Antin, who has had only one relapse on Tysabri and just returned from sailing a 50-foot catamaran with a group of friends in the British Virgin Islands. If the alternative is that I die, I would rather that than lose the … Continue reading

Posted in MS Treatment | Comments Off on MS Patients Choose Death Risk With Potent Drug Treatment

A pan-European study: Signs of motor disorders can appear years before disease manifestation

Posted: Published on May 23rd, 2013

Public release date: 22-May-2013 [ | E-mail | Share ] Contact: Marcus Neitzert marcus.neitzert@dzne.de 49-228-433-02271 Helmholtz Association of German Research Centres The scientists report these findings in the current online edition of "The Lancet Neurology". This pan-European study could open up new possibilities of early diagnosis and smooth the way for treatments which tackle diseases before the patient's nervous system is irreparably damaged. "Spinocerebellar ataxias" comprise a group of genetic diseases of the cerebellum and other parts of the brain. Persons affected only have limited control of their muscles. They also suffer from balance disorders and impaired speech. The symptoms originate from mutations in the patient's genetic make-up. These cause nerve cells to become damaged and to die off. Such genetic defects are comparatively rare: it is estimated that about 3,000 people in Germany are affected. It is known that there are various subtypes of these neurodegenerative diseases. The age at which the symptoms manifest consequently fluctuates between about 30 and 50. "Our aim was to find out whether specific signs can be recognized before a disease becomes obvious," says project leader Prof. Thomas Klockgether, Director for Clinical Research at the DZNE and Director of the Clinic for Neurology at … Continue reading

Comments Off on A pan-European study: Signs of motor disorders can appear years before disease manifestation

Fundamentals of Bio-Identical Hormone Therapy – Video

Posted: Published on May 23rd, 2013

Fundamentals of Bio-Identical Hormone Therapy For more information, visit http://www.MedicineCoach.com. By: West Conner … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Fundamentals of Bio-Identical Hormone Therapy – Video

Responsive Mobile Website Launched for Hormone Replacement Therapy

Posted: Published on May 23rd, 2013

WASHINGTON, DC--(Marketwired - May 21, 2013) - Plastic surgeon Dr. Mark Richards recently launched a new version of his website catering to his hormone replacement therapy patients in the Maryland, Northern Virginia, and Washington, DC areas. The new mobile site will now utilize responsive technology, meaning the site will automatically adjust to fit the screen of the device being used to view it. As the screen adjusts, it provides the viewer with a user-friendly format that makes it easy to access all of the necessary information without confusion. Dr. Richards says this new website will allow his current and prospective patients to gain more information about bio-identical pellet therapy quickly and easily. In order to stay on top of the changes in technology, Dr. Richards felt that accommodating how his patients access information was extremely important. His new responsive website will make it easy to view and navigate on any device, regardless of screen size. Patients will be able to access a wealth of information about bio-identical hormone replacement therapy (BHT), and why it is a helpful treatment for many people. His site features information about: The website also offers information for physicians interested in offering BHT to their patients, … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Responsive Mobile Website Launched for Hormone Replacement Therapy

Stem-cell cloner acknowledges errors in groundbreaking paper

Posted: Published on May 23rd, 2013

Shoukhrat Mitalipov says honest mistakes were made in a push to get cloning results published quickly. Richard Clement/Reuters A blockbuster paper that reported the creation of human stem cell lines via cloning has come under fire. An anonymous online commenter found four problems in the paper, which was published online 15 May in the journal Cell1. The lead author of the Cell paper, Shoukhrat Mitalipov, told Nature that three were innocent mistakes made while assembling the data in what was to many in the field an unfathomable rush to publication: just three days from submission to acceptance and another 12 days to publication. The fourth, Mitalipov said, was not a problem at all. The results are real, the cell lines are real, everything is real, says Mitalipov, a reproductive biology specialist at the Oregon Health and Science University in Beaverton. Mitalipov said he had just returned from Europe on Wednesday and found himself swamped with emails and calls from editors at Cell, as well as from journalists. I just got home a couple hours ago. The editors, everyone was going crazy, he says. Mitalipov says he consulted with first author Masahito Tachibana, who compiled the data for the paper, and … Continue reading

Posted in Stem Cell Research | Comments Off on Stem-cell cloner acknowledges errors in groundbreaking paper

Largest genetic sequencing study of human disease completed

Posted: Published on May 23rd, 2013

Washington, May 23 (ANI): A global team of scientists has completed the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases. The exact cause of these diseases - autoimmune thyroid disease, coeliac disease, Crohn's disease, psoriasis, multiple sclerosis and type 1 diabetes- is unknown, but is believed to be a complex combination of genetic and environmental factors. In each disease only aproportion of the heritability is explained by the identifiedgenetic variants. The techniques used to date, have generally identified common (in the population) variants of weak effect. In this study, using high-throughput sequencing techniques, the team led by researchers from Queen Mary, University of London, sought to identify new variants, including rare and potentially high risk ones, in 25 previously identified risk genes in a sample of nearly 42,000 individuals (24,892 with autoimmune disease and 17,019 controls). It has been suggested - in the 'rare-variant synthetic genome-wide association hypothesis' - that a small number of rare variants in risk genes are likely to be a major cause of the heritability of these conditions. However, the study suggests that the genetic risk of these diseasesmore likely involves a complex combination of hundreds of weak-effect … Continue reading

Comments Off on Largest genetic sequencing study of human disease completed

Measuring The Health Of Human Genetic Material In Relation To A Patient's Age

Posted: Published on May 23rd, 2013

May 23, 2013 Lee Rannals for redOrbit.com Your Universe Online A new technique featured in the Journal of Visualized Experiments (JoVE) could lead to the development of a genetic thermometer that could assess a patients health in relation to other individuals. The method developed by the laboratory of Dr. Gil Atzmon at New Yorks Albert Einstein College of Medicine measures telomere length, which serve as the caps to chromosomes. Telomeres mark the ends of genetic material and ensure that genes do not degrade as cells divide. Think of telomere length as though it was a thermometer. It measures the health of your genetic material, Dr. Atzmon explains. It tells you how fit you are in relation to the age you are. If you have longer telomeres you are in good shape, if you have shorter telomeres you are less fit for your age and are not in good health. Telomerase activity eclipses as people age, and as a result telomeres shorten and can be responsible for age related afflictions and some cancers. An individuals overall health can impact how quickly these telomeres degrade. Telomere length and telomerase function impacts several realms of biological and medical research- from preventative aging models … Continue reading

Comments Off on Measuring The Health Of Human Genetic Material In Relation To A Patient's Age

California bill would prevent genetic-testing firms from using surreptitiously obtained DNA

Posted: Published on May 23rd, 2013

If you want to keep your DNA to yourself, be sure not to leave any stray hairs, Q-tips or underwear lying around. There are genetic testing companies out there willing to reveal your most intimate biological secrets to anybody -- without your knowledge or permission. And under California law, such genetic snooping is perfectly legal. Now, legislators in Sacramento are considering a bill to change that. Senate Bill 222, which faces a key hearing Thursday, would require a donor's consent to collect, analyze or share genetic information. While the legislation might seem like a slam-dunk in the ever-evolving battle between technology and privacy, it's generating opposition from unlikely quarters: major research universities such as Stanford and the University of California, which argue that providing those protections will create unnecessary red tape and costs. "We have privacy laws in place to protect health and financial information," said the bill's author, Alex Padilla, D-Pacoima. "But arguably the most personal information about us -- our own genetic profile -- isn't protected." Most Californians are probably familiar with genetic testing companies such as 23AndMe that will screen customers' DNA for their predisposition to cancer, diabetes, Parkinson's, Alzheimer's and a host of other diseases. But … Continue reading

Comments Off on California bill would prevent genetic-testing firms from using surreptitiously obtained DNA

Genetic marker associated with risk for pulmonary fibrosis

Posted: Published on May 23rd, 2013

Public release date: 21-May-2013 [ | E-mail | Share ] Contact: Lori J. Schroth ljschroth@partners.org 617-534-1604 Brigham and Women's Hospital Boston, MA New research from Brigham and Women's Hospital (BWH) finds that a genetic risk factor for pulmonary fibrosis, an uncommon but deadly lung disease, may be effective in identifying individuals at risk for this disease. These findings will be presented at the American Thoracic Society International Conference and publish online simultaneously at the New England Journal of Medicine on May 22 and will appear in the July 4, 2013 print edition. "While this variant of the MUC5B gene is fairly common, pulmonary fibrosis is not. Our findings suggest that pulmonary fibrosis may be a part of a much more common, but likely less severe, syndrome and could potentially be predicted on the basis of the MUC5B genetic variant," said Gary M. Hunninghake, MD, MPH, a physician researcher in the pulmonary and critical care division at BWH and co-corresponding author of the research paper. "While too early to tell how important this variant may be in clinical practice, this finding could open new research avenues into this disease." Researchers looked at a common variant of the gene for mucin-5B, a … Continue reading

Comments Off on Genetic marker associated with risk for pulmonary fibrosis

Page 5,267«..1020..5,2665,2675,2685,269..5,2805,290..»